[CNCR] Loncar|Cancer|Immunotherapy|ETF
Overview
Type of security: Fund
Tags:
The data is delayed by 15 minutes.
Strongest Trends Summary For CNCR
CNCR is in the medium-term down -11% below S&P in 4 months. In the long-term down -35% below S&P in 1 year and down -59% below S&P in 5 years.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Technical Data
| High 52 week | 28.52 | Low 52 week | 17.21 | Last close | 20.42 | Last change | -0.56% |
| RSI | 46.24 | Average true range | 0.46 | Beta | 1.41 | Volume | |
| Simple moving average 20 days | 0.14% | Simple moving average 50 days | -2.01% | Simple moving average 200 days | -5.69% |
Performance Data
| Performance Week | -0.9% | Performance Month | 1.78% | Performance Quart | -7.75% | Performance Half | -0.85% |
| Performance Year | -27.96% | Performance Year-to-date | 8.17% | Volatility daily | 1.76% | Volatility weekly | 3.94% |
| Volatility monthly | 8.08% | Volatility yearly | 27.98% | Relative Volume | Average Volume | 9.2 K | |
| New High | New Low |
Funds Characteristics
| 30-day SEC yield | Average market capitalization | Average weighted market capitalization | Forward P/E | ||||
| Gross expense ratio | Index dividend yield | Median market cap | Number of holdings | ||||
| Price to Book Value | Price to Earnings | Total expense ratio | Total net assets | ||||
| Weighted market capitalization |
News
2019-05-09 07:46:00 | These 3 revolutionary genomics companies are changing lives for patients — and investors
2019-03-20 07:00:00 | Don't Fall for a Good Story
2019-03-12 11:05:03 | Trump Proposes 2020 Budget: ETFs to Top & Flop
2019-03-11 10:59:02 | Best and Worst ETFs of Last Week
2019-03-06 17:05:29 | Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook
2019-02-06 14:32:13 | Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results
2018-08-16 11:49:21 | Hone In On Health Care In China With This New ETF
2018-08-15 08:00:00 | Loncar China BioPharma ETF CHNA Launches on Nasdaq
2018-08-02 12:55:00 | Adding Biotech ETFs to Your Portfolio
2018-08-02 10:47:18 | 5 Strong Healthcare ETFs to Buy
2018-06-28 06:56:00 | The Do’s and Don’ts of Trading ETFs
2018-04-18 16:08:08 | Why These Small Cap Biotech ETFs are Soaring
2018-04-11 21:26:04 | Biotech ETFs Go Under the Microscope
2018-03-16 13:30:05 | Here's an ETF to Invest in Immunotherapy--the Game Changing Cancer Treatment
2018-02-28 14:09:04 | The 10 Best ETFs of February 2018
2018-02-20 09:24:02 | Biotech ETF CNCR Hits New 52-Week High
2018-02-16 08:00:00 | Loncar Cancer Immunotherapy ETF CNCR Surpasses $50 Million in Assets Under Management
2018-02-02 08:00:32 | The 10 Best ETFs of January 2018
2017-12-20 08:00:00 | Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
2017-12-18 14:40:00 | 5 Secret Santa ETFs and Stocks to Buy Ahead of Christmas
2017-11-14 16:18:14 | Biotechs Sell Off In Droves — Are Investors Seeking Mergers?
2017-10-04 08:00:00 | Loncar Cancer Immunotherapy Index Announces Merger Replacements
2017-09-01 14:06:06 | Top ETF Stories of August
2017-08-28 14:37:23 | Biotech ETFs Jump on Gilead, Kite Deal
2017-06-22 16:02:08 | Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
2017-06-21 08:30:00 | Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
2017-06-02 06:56:45 | Cancer drug prices could double or triple thanks to this popular but unproven drug trend
2017-06-01 15:20:27 | Cancer drug prices could double or triple thanks to this popular but unproven drug trend
2017-01-11 16:37:22 | US STOCKS-Wall Street ends choppy session higher, health lags on Trump comments
2017-01-11 14:38:27 | US STOCKS-Nasdaq drops with pharma stocks as Trump blasts drug prices
2016-11-16 17:22:10 | Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
2016-10-25 12:47:00 | How To Pick The Best ETF
2016-10-14 08:30:00 | Cancer Immunotherapy ETF Celebrates One-Year Anniversary
2016-08-02 12:09:06 | A bunch of Wall Street pros are getting bullish on health care
2016-06-22 07:30:00 | Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
2016-06-01 09:23:00 | 3 High-Growth ETFs to Supercharge Your Portfolio
2016-04-12 16:22:00 | Here's Why Advaxis Inc.'s Stock Roared Higher in March
2016-04-12 16:22:00 | Here's Why Advaxis Inc.'s Stock Roared Higher in March
2016-03-07 06:37:00 | How ISE Builds ETF Partnerships
2016-02-05 06:46:00 | Cancer ETF Redefines Biotech Investing
2016-01-08 13:33:00 | ‘Lucky Years’ Author Dr. David Agus Points to the Next Big Things in Health Care
2015-12-14 17:46:00 | Cancer Immunotherapy ETF Offers High Growth Investing Potential
2015-10-16 15:23:07 | 5 Immunotherapy Stocks to Watch for Treating Cancer
2015-10-16 12:12:18 | There's an ETF for that: Industry sets record
2015-10-15 17:15:00 | New biotech ETF
CNCR motifs
There is no motif for this symbol